0 Комментарии
0 Поделились
60 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Long-Acting Injectable Oncology Drug Market Segmentation & Forecast, Share, SizeFuture of Executive Summary Long-Acting Injectable Oncology Drug Market Market: Size and Share Dynamics The global long-acting injectable oncology drug market size was valued at USD 7.16 billion in 2025 and is expected to reach USD 17.60 billion by 2033, at a CAGR of 11.90% during the forecast period. A DBMR team of experts and professionals from a number of...0 Комментарии 0 Поделились 272 Просмотры 0 предпросмотр
-
Long-Acting Injectable Oncology Drug Market Size, Share, Segments and TrendExecutive Summary Long-Acting Injectable Oncology Drug Market Growth Trends and Share Breakdown The global long-acting injectable oncology drug market size was valued at USD 7.16 billion in 2025 and is expected to reach USD 17.60 billion by 2033, at a CAGR of 11.90% during the forecast period. This global Long-Acting Injectable Oncology Drug Market...0 Комментарии 0 Поделились 57 Просмотры 0 предпросмотр
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Комментарии 0 Поделились 99 Просмотры 0 предпросмотр
-
Emerging Therapies Transforming the Sarcoma Drugs IndustryImmunotherapy is emerging as a promising treatment approach.Checkpoint inhibitors are being evaluated for sarcoma cases.Combination therapies are improving patient survival outcomes. The Sarcoma Drugs Market is projected to witness steady growth, registering a CAGR of 7.9% from 2025 to 2031. The market size is expected to expand from US$ XX million in 2024 to US$ XX million by 2031, driven by...0 Комментарии 0 Поделились 781 Просмотры 0 предпросмотр
-
Future of Radiation Protection: Anti-Radiation Drugs Market InsightsThe market is gaining traction as cancer treatment protocols increasingly incorporate radiation therapy. The need to reduce therapy-related toxicity is boosting adoption of anti-radiation drugs. Continuous innovation is expanding therapeutic applications. Future OutlookThe Anti-Radiation Drugs Market is expected to register a CAGR of 6.8% from 2025 to 2031, with a market size expanding from US$...0 Комментарии 0 Поделились 469 Просмотры 0 предпросмотр
-
Global Bladder Cancer Market Trends Shaping Treatment FutureThe rising aging population remains a key growth factor for the market.Older adults face higher risks of bladder cancer, increasing treatment demand.Healthcare systems are responding with improved therapeutic and diagnostic infrastructure. 5. The Bladder Cancer Therapeutics and Diagnostics Market is projected to register a robust CAGR of 10.2% from 2025 to 2031, with market size expanding...0 Комментарии 0 Поделились 680 Просмотры 0 предпросмотр
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Комментарии 0 Поделились 20 Просмотры 0 предпросмотр
-
Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...0 Комментарии 0 Поделились 184 Просмотры 0 предпросмотр
-
Rising Demand for Precision Oncology Boosting Sarcoma Drugs Market GrowthAdvancements in precision medicine are positively influencing the Sarcoma Drugs Market. Personalized therapies are helping physicians deliver more effective treatments for sarcoma patients. This approach is expected to drive significant market growth over the forecast period. The Sarcoma Drugs Market is expected to register a CAGR of 7.9% from 2025 to 2031, with the market size expanding from...0 Комментарии 0 Поделились 709 Просмотры 0 предпросмотр
-
Unpacking Oncology Small Molecule Drugs Market Growth, Opportunities, Drivers, Strategies, Trends, and Forecast to 2031The Oncology Small Molecule Drugs Market is experiencing significant evolution as stakeholders across the pharmaceutical and biotechnology landscape intensify innovation efforts to address the growing global cancer burden. According to the Oncology Small Molecule Drugs Market report by The Insight Partners, the market is projected to grow at a compound annual growth rate (CAGR) of 5.6% from...0 Комментарии 0 Поделились 259 Просмотры 0 предпросмотр
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek
